Monitoring vital signs in newborns to improve care
Neo-vital: Investigating Changes in Vital Signs in Neonates
This study looks at how different treatments affect the vital signs of newborns in a neonatal care unit to help doctors create better, personalized care plans for each baby.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200 (estimated) |
| Ages | N/A to 42 Weeks |
| Sex | All |
| Sponsor | University of Oxford Academic / other |
| Locations | 1 site (Oxford) |
| Trial ID | NCT06032494 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on understanding how various medical procedures and medications affect the vital signs of newborns in a neonatal care unit. By continuously monitoring heart rate, respiration, and oxygen saturation, the study aims to identify patterns in how different infants respond to treatments. The goal is to develop predictive models that can help healthcare providers tailor individualized care plans based on each infant's baseline vital signs. This approach could enhance the safety and effectiveness of treatments administered to vulnerable newborns.
Who should consider this trial
Good fit: Ideal candidates for this study are infants born to mothers aged 16 or over who are admitted to the Newborn Care Unit at John Radcliffe Hospital.
Not a fit: Infants with known chromosomal abnormalities or life-threatening congenital conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more personalized and safer treatment options for newborns requiring neonatal care.
How similar studies have performed: While this approach is observational and builds on existing practices, similar studies have shown promise in improving individualized care in neonatal settings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Infants will be eligible to be included in the study if they are: * Born to, or expected to be born to, a mother aged 16 or over * Admitted to the Newborn Care Unit, John Radcliffe Hospital, or anticipated delivery of a baby who will require admittance to the Newborn Care Unit at birth * Mother given informed written consent Exclusion Criteria: Infants will be ineligible if the following exclusion criteria applies: • Known chromosomal abnormality or life-threatening congenital abnormality
Where this trial is running
Oxford
- John Radcliffe Hospital — Oxford, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Caroline Hartley, PhD
- Email: caroline.hartley@paediatrics.ox.ac.uk
- Phone: +44 1865 234537
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.